Melanie Truong-Le, DO, OD


Addressing the Current State of Care, Pipeline in NMOSD: Melanie Truong-Le, DO, OD

The neuro-ophthalmologist at UT Southwestern further discussed the high cost of treatment for patients with neuromyelitis optica spectrum disorder and the need to improve access to care.

Wendy Troxel, PhD


The Science of Sleep Health and Romantic Relationships: Wendy Troxel, PhD

For Valentine’s Day, the senior behavioral scientist at the RAND Corporation talked about the significance of sleep health and romantic relationships [WATCH TIME: 5 minutes]

Devon Conway, MD


Choosing Therapies for Patients With MS: Devon Conway, MD

The staff neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic outlined the process of choosing a therapy for patients with multiple sclerosis. [WATCH TIME: 4 minutes]

Michael J. Soileau, MD


The Challenges and Innovations in Parkinson Treatment: Michael Soileau, MD, FAAN

The movement disorder specialist at Texas Movement Disorder Specialists talked about the complexities and advancements in treating Parkinson disease, emphasizing the need for strategic and aggressive treatment approaches despite administrative burdens. [WATCH TIME: 5 minutes]

Charles Lockwood, MD


AUPN Leading Edge Episode 2: So You Want to Be a Dean? Pros, Cons, Joys and Tribulations

AUPN Leading Edge Episode 2 features Clifton Gooch, MD, and Charles Lockwood, MD, who explore making the leap from chair to dean. [LISTEN TIME: 25 minutes]

David B. Duncan, MD


New Horizons in Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.

Wolfgang Muhlhofer, MD


AUPN 2022 Spring Chairs Session: Simulations for Training in Neurology

David G. Standaert, MD, PhD; Wolfgang Muhlhofer, MD; and Latisha Sharma, MD, share their experience in applying simulation-based learning in Neurology and will discuss the current state and future potential of this approach. [WATCH TIME: 1 hour, 25 minutes]

Iryna Leunikava, MSc


Insights on Seizure Therapy and Future Plans in Epilepsy Research: Iryna Leunikava, MSc

The European evidence generation strategy lead for epilepsy and rare syndromes at UCB described some details about further epilepsy research and other explorations in the next few years. [WATCH TIME: 3 minutes]

Orrin Devinsky, MD


Challenges With Identifying Convulsive Events to Prevent Sudden Death in Toddlers: Orrin Devinsky, MD

The director of NYU Langone’s Comprehensive Epilepsy Center discussed the infrequent prevalence of febrile seizures in toddlers prior to sudden death and the difficulty with toeing the line on being overly cautious and reasonable. [WATCH TIME: 4 minutes]

Barry Hendin, MD


Clinical Pearls for the Management of MS

Expert neurologists emphasize the importance of conversations around patient lifestyle, mental health, and comorbid conditions as keys to improve care for MS.

Sean Pittock, MD


Ravulizumab’s Long-Term Efficacy and Safety as NMOSD Treatment: Sean Pittock, MD

The director for the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology provided an overview of the open-label extension of the phase 3 CHAMPION-NMOSD trial and how the newly approved ravulizumab fits with other NMOSD treatments. [WATCH TIME: 4 minutes]

Alesa Monk, MBA


Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMA

Advocacy organization Cure SMA provides insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in SMA.

Tom Frontera, MD


AUPN Leadership Minute Episode 40: Funding Resident and Fellow Positions

Episode 40 of the AUPN Leadership Minute features Clifton L. Gooch, MD, of the University of South Florida; and Tom Frontera, MD, of the University of South Florida. [WATCH TIME: 9 minutes]

Rebecca Gottesman, MD, PhD, FANA


Changes in Themes Across Neurology Over the Years: Rebecca Gottesman, MD, PhD, FANA; Frances E. Jensen, MD, FACP

The president of the ANA and the chair of the annual meeting programming committee provided commentary on the advances in neurology and the shift in how clinicians approach and treat diseases once thought to be fatal. [WATCH TIME: 6 minutes]

Jonna Lorenz


SARS-CoV-2 May Alter Blood-Brain Barrier Function

There is no evidence yet that SARS-CoV-2 can pass the blood-brain barrier, though its effects on the barrier may be intensified in those with dementia.

Darin T. Okuda, MD, FAAN, FANA


Future Research Objectives and Questions for Radiologically Isolated Syndrome: Darin Okuda, MD, FAAN, FANA

The director of Neuroinnovation and Multiple Sclerosis & Neuroimmunology Imaging Program at UT Southwestern Medical Center discussed ways to build off the ARISE study and the unanswered questions regarding radiologically isolated syndrome. [WATCH TIME: 3 minutes]

Khashayar Dashtipour, MD, PhD


Managing Safety Concerns with ITB Pump

A panel of experts discuss safety concerns with intrathecal baclofen ITB pumps.

Katherine Wang, MD


Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Tally Largent-Milnes, PhD


The Endocannabinoid System and its Relationship to Migraine: Tally Largent-Milnes, PhD

The assistant professor of pharmacology at the University of Arizona College of Medicine Tucson shared her insight into the endocannabinoid system and its therapeutic potential in treating migraine. [WATCH TIME: 5 minutes]

Edritz Javelosa, PhD


Lessons Learned and Future Possibilities in ALS Collaborations: Edritz Javelosa, PhD

At the 2023 MDA conference, the scientific research portfolio director at Muscular Dystrophy Association detailed a session on collaborative research in ALS and ongoing efforts in the field. [WATCH TIME: 3 minutes]

Jacqueline Montes, PT, EdD


Prescribing Psychical Activity Regimens in Spinal Muscular Atrophy: Jacqueline Montes, PT, EdD

The associate professor of rehabilitation and regenerative medicine at Columbia University Medical Center discussed the ways clinicians go about properly prescribing exercise regimens for patients with spinal muscular atrophy. [WATCH TIME: 3 minutes]

Ryan Haumschild, PharmD, MS, MBA


The Evolving Impact of Biosimilars and Pharmacists When Treating Multiple Sclerosis: Ryan Haumschild, PharmD, MS, MBA

The director of pharmacy at Emory Healthcare and Winship Cancer Institute talked about the role of pharmacists in multiple sclerosis patient care and collaborating with providers as biosimilars become available. [WATCH TIME: 5 minutes]

Ralph Nixon, MD, PhD


Redefining the Understanding of Alzheimer Disease and Its Pathology: Ralph Nixon, MD, PhD

The professor of psychiatry and cell biology at NYU Langone provided commentary on new findings which challenge traditional theories on the root of Alzheimer disease and how it is targeted. [WATCH TIME: 17 minutes]

Jaime Imitola, MD


A Call to Action to Address Disparities in Multiple Sclerosis Care: Jaime Imitola, MD

The chief of the Division of MS and Neuroimmunology at UConn Health talked about the challenges with access to care in multiple sclerosis, particularly for marginalized communities, despite significant progress made in the field over the past decades. [WATCH TIME: 4 minutes]

G. Abbas Kharal, MD, MPH


Advanced Imaging for Extended Stroke Treatment

With many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.

Sandi Lam, MD, MBA


How Surgical Interventions Improve Survival Rate in Pediatric Epilepsy: Sandi K. Lam, MD, MBA

The division chief of pediatric neurosurgery at Ann & Robert H. Lurie Children's Hospital of Chicago talked about findings from a recently published study on long-term survival of pediatric patients with drug-resistant epilepsy which was presented at AES 2023. [WATCH TIME: 6 minutes]

Terrence L. Fisher, PhD


Mechanistic Potential of Pepinemab, a SEMA4D-Blocking Antibody: Terrence L. Fisher, PhD

The senior vice president of clinical development at Vaccinex provided commentary on a presentation from CTAD 2023 highlighting the therapeutic potential of peptinemab, an agent that’s shown success in Huntington disease, in patients with Alzheimer disease. [WATCH TIME: 3 minutes]

© 2024 MJH Life Sciences

All rights reserved.